HERG trafficking and pharmacological rescue of LQTS-2 mutant channels.

The human ether-a-go-go-related gene (hERG) encodes an ion channel subunit underlying IKr, a potassium current required for the normal repolarization of ventricular cells in the human heart. Mutations in hERG cause long QT syndrome (LQTS) by disrupting IKr, increasing cardiac excitability and, in some cases, triggering catastrophic torsades de pointes arrhythmias and sudden death. More than 200 putative disease-causing mutations in hERG have been identified in affected families to date, but the mechanisms by which these mutations cause disease are not well understood. Of the mutations studied, most disrupt protein maturation and reduce the numbers of hERG channels at the membrane. Some trafficking-defective mutants can be rescued by pharmacological agents or temperature. Here we review evidence for rescue of mutant hERG subunits expressed in heterologous systems and discuss the potential for therapeutic approaches to correcting IKr defects associated with LQTS.

[1]  W. Balch,et al.  Rab1 Interaction with a GM130 Effector Complex Regulates COPII Vesicle cis‐Golgi Tethering , 2001, Traffic.

[2]  M. Sanguinetti,et al.  Molecular Genetic Insights into Cardiovascular Disease , 1996, Science.

[3]  C. January,et al.  Novel mechanism associated with an inherited cardiac arrhythmia: defective protein trafficking by the mutant HERG (G601S) potassium channel. , 1999, Circulation.

[4]  A. Brown,et al.  Role of the Cytosolic Chaperones Hsp70 and Hsp90 in Maturation of the Cardiac Potassium Channel hERG , 2003, Circulation research.

[5]  N. Copeland,et al.  Two isoforms of the mouse ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. , 1997, Circulation research.

[6]  John Geibel,et al.  Calcium-pump inhibitors induce functional surface expression of ΔF508-CFTR protein in cystic fibrosis epithelial cells , 2002, Nature Medicine.

[7]  Y. Sagara,et al.  Thapsigargin, a high affinity and global inhibitor of intracellular Ca2+ transport ATPases. , 1992, Archives of biochemistry and biophysics.

[8]  E. Green,et al.  A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome , 1995, Cell.

[9]  C. January,et al.  Long QT Syndrome: , 2000, Journal of cardiovascular electrophysiology.

[10]  M. Sanguinetti,et al.  A mechanistic link between an inherited and an acquird cardiac arrthytmia: HERG encodes the IKr potassium channel , 1995, Cell.

[11]  D. Roden,et al.  A K+ Channel Splice Variant Common in Human Heart Lacks a C-terminal Domain Required for Expression of Rapidly Activating Delayed Rectifier Current* , 1998, The Journal of Biological Chemistry.

[12]  G. Robertson,et al.  HERG, a human inward rectifier in the voltage-gated potassium channel family. , 1995, Science.

[13]  Rebecca A. Ayers,et al.  Interaction with GM130 during HERG Ion Channel Trafficking , 2002, The Journal of Biological Chemistry.

[14]  G. Warren,et al.  The Vesicle Docking Protein p115 Binds GM130, a cis-Golgi Matrix Protein, in a Mitotically Regulated Manner , 1997, Cell.

[15]  D. Roden,et al.  Torsade de pointes , 1993, Clinical cardiology.

[16]  C. January,et al.  Pharmacological Rescue of Human K+ Channel Long-QT2 Mutations: Human Ether-a-Go-Go-Related Gene Rescue Without Block , 2002, Circulation.

[17]  T. McDonald,et al.  14‐3‐3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity , 2002, The EMBO journal.

[18]  B. Schwappach,et al.  14-3-3 Dimers Probe the Assembly Status of Multimeric Membrane Proteins , 2003, Current Biology.

[19]  F. Lang,et al.  Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and astemizole , 1996, FEBS letters.

[20]  J. Warmke,et al.  A family of potassium channel genes related to eag in Drosophila and mammals. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[21]  C. January,et al.  Thapsigargin Selectively Rescues the Trafficking Defective LQT2 Channels G601S and F805C* , 2003, Journal of Biological Chemistry.

[22]  P. C. Viswanathan,et al.  Novel characteristics of a misprocessed mutant HERG channel linked to hereditary long QT syndrome. , 2000, American journal of physiology. Heart and circulatory physiology.

[23]  A. Luini,et al.  The GM130 and GRASP65 Golgi proteins cycle through and define a subdomain of the intermediate compartment , 2001, Nature Cell Biology.

[24]  E. Jones,et al.  Cardiac IKr Channels Minimally Comprise hERG 1a and 1b Subunits* , 2004, Journal of Biological Chemistry.

[25]  C. January,et al.  Biology of cardiac arrhythmias: ion channel protein trafficking. , 2004, Circulation research.

[26]  C. January,et al.  Role of glycosylation in cell surface expression and stability of HERG potassium channels. , 2002, American journal of physiology. Heart and circulatory physiology.

[27]  Ari Helenius,et al.  Quality control in the endoplasmic reticulum , 2003, Nature Reviews Molecular Cell Biology.

[28]  C. January,et al.  HERG Channel Dysfunction in Human Long QT Syndrome , 1998, The Journal of Biological Chemistry.

[29]  C. Obejero-Paz,et al.  Retention in the endoplasmic reticulum as a mechanism of dominant-negative current suppression in human long QT syndrome. , 2000, Journal of molecular and cellular cardiology.

[30]  C. January,et al.  Correction of Defective Protein Trafficking of a Mutant HERG Potassium Channel in Human Long QT Syndrome , 1999, The Journal of Biological Chemistry.

[31]  L. Wang,et al.  Electrophysiological characterization of an alternatively processed ERG K+ channel in mouse and human hearts. , 1997, Circulation research.